DE1525541U - - Google Patents

Info

Publication number
DE1525541U
DE1525541U DENDAT1525541D DE1525541DU DE1525541U DE 1525541 U DE1525541 U DE 1525541U DE NDAT1525541 D DENDAT1525541 D DE NDAT1525541D DE 1525541D U DE1525541D U DE 1525541DU DE 1525541 U DE1525541 U DE 1525541U
Authority
DE
Germany
Prior art keywords
iwt
dwr
becomes
bwi
diw
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1525541D
Other languages
German (de)
English (en)
Publication of DE1525541U publication Critical patent/DE1525541U/de
Active legal-status Critical Current

Links

Landscapes

  • Exhaust Gas After Treatment (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Developing Agents For Electrophotography (AREA)
DENDAT1525541D Active DE1525541U (OSRAM)

Publications (1)

Publication Number Publication Date
DE1525541U true DE1525541U (OSRAM)

Family

ID=826748

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1525541D Active DE1525541U (OSRAM)

Country Status (1)

Country Link
DE (1) DE1525541U (OSRAM)

Similar Documents

Publication Publication Date Title
CN100522080C (zh) 外科夹具推进和对准机构
Chesney Adherence to HAART regimens
Campbell et al. Sclerosing peritonitis: identification of diagnostic, clinical, and radiological features
Hoenig et al. The nosological position of transsexualism
DE1525541U (OSRAM)
Gotuzzo et al. Ciprofloxacin for the treatment of cholera: a randomized, double-blind, controlled clinical trial of a single daily dose in Peruvian adults
Cao et al. Sodium-glucose cotransporter 2 inhibitors benefit to kidney and cardiovascular outcomes for patients with type 2 diabetes mellitus and chronic kidney disease 3b-4: A systematic review and meta-analysis of randomized clinical trials
Guevara et al. Takotsubo cardiomyopathy complicated with acute pericarditis and cardiogenic shock
Groop et al. Treatment strategies for secondary sulfonylurea failure. Should we start insulin or add metformin? Is there a place for intermittent insulin therapy?
Mackay et al. Failure of lithium treatment in established tardive dyskinesia
Angulo et al. A phase 2b, dose-selection study evaluating the efficacy and safety of oral ibrexafungerp vs fluconazole in vulvovaginal candidiasis (DOVE)
Cohen et al. A comparative study of streptomycin and dihydrostreptomycin in pulmonary tuberculosis
Conway et al. A systematic approach to the treatment of HIV and hepatitis C virus infection in the inner city: a Canadian perspective
CA2246407A1 (en) Use of inhibitors of the sodium-hydrogen exchanger for the production of a pharmaceutical for the treatment of disorders which are caused by protozoa
Berger Theileria velifera demonstrated in cattle in the Eastern Cape Province of the Republic of South Africa
ELLIS-PEGLER The effects of World Health Organization chemotherapy on imported leprosy in Auckland, New Zealand, 1983-90
Niang et al. Controlled Trial of 3-Day
Pettigiani The Meaning of the Female Presence in Messianic Texts within the Corpus of the Nevi’im
Wong et al. Proposal to Hamas: 6-Week Pause in Strife and Hostage-Prisoner Swap.
Bruyn Study regimen changes
Thomas et al. Experiments with antimalarial drugs in man: I. The Protective Effect of Proguanil (“Paludrine”) against an East African strain of Plasmodium falciparum transmitted by Anopheles gambiae
Tabidze et al. P694 Case-based enhanced gonorrhea surveillance, chicago, IL, 2018
Shabuj et al. Gentamicin in newborn sepsis: Once daily dose versus twice daily dose
Kersh et al. P693 Neisseria gonorrhoeae in-vitro susceptibilities to ceftriaxone, cefixime and azithromycin in GISP isolates, 1987–2017
Luger Antibiotic treatment of venereal diseases